跳至主要内容
临床试验/NCT05165173
NCT05165173已完成不适用

Almond Milk With Vitamin D: Impact on Vitamin D Status

University of Florida2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2023年5月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
2
主要终点
Vitamin D

研究概览

简要总结

The overall goal is to enhance vitamin D status in a safe and effective manner. A 3-week randomized comparator-controlled trial among a cohort of adults with CKD (stages 3-5) (n=24) will test the main objective: Evaluate the bioefficacy of D3 in micro- and nanoparticles (4000IUs) in almond milk with the sub-objective of: Explore the effect of D3 in micro- and nanoparticles (4000IUs) in almond milk on inflammation markers CRP, TNF-α and IL-6.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

盲法说明

Participants will receive a coded sample that either contains 4000 IUs microparticles of vitamin D or 4000 IUs nanoparticles of vitamin D

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults who have been diagnosed with CKD
  • have no GI disorders or GI disturbances
  • age 18 years or older
  • no food allergies or dietary restrictions
  • all with no contraindications to consuming anything by mouth as per their physician

排除标准

  • no diagnosis of CKD
  • GI disorders
  • gastrointestinal disturbances
  • under 18 years old
  • food allergies to almonds
  • Dietary restrictions as medically indicated
  • trouble chewing/swallowing as confirmed by physician

结局指标

主要结局

Vitamin D

时间窗: 21 days

baseline to end line in the concentration of serum 25(OH)D3 between and within the control and intervention groups.

次要结局

  • Calcium(21 days)
  • PTH(21 days)
  • IL-6(21 days)
  • TNF-alpha(21 days)
  • parent vitamin D(21 days)
  • C-reactive protein(21 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验